Transcranial Direct Current Stimulation to Reduce Chronic Pelvic Pain in Endometriosis

Endometriosis Clinical Trial

Official title:

Transcranial Direct Current Stimulation to Reduce Chronic Pelvic Pain in Endometriosis

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05231239
• Other study ID #: EA1/174/19
• Status: Recruiting
• Phase: Phase 2
• Start date: January 1, 2021
• Est. completion date: January 2023

Study information

• Verified date: February 2022
• Source: Charite University, Berlin, Germany
• Contact: Magdalena S Prüß, MD
• Phone: +493084452711
• Email: magdalena.pruess[@]charite.de
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In the study it will be tested whether transcranial direct current stimulation can reduce the perception of pelvic pain in patients with endometriosis.

Hypothesis: Transcranial direct current stimulation can reduce the perception of pelvic pain in patients with patients with endometriosis.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: January 2023
• Est. primary completion date: January 2023
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

Endometriosis Chronic pain (more than 3 months) Pain (VAS > 3/10)

Exclusion Criteria:

• Contraindication to transcranial direct current stimulation Pregnancy Sever internal or psychiatric condition

Related Conditions & MeSH terms

• Endometriosis
• Pelvic Pain

Intervention

Device:
• tDCS : Transcranial direct current stimulation
Transcranial direct current stimulation

Locations

Country	Name	City	State
Germany	Charite University Medicine	Berlin

Sponsors (1)

Lead Sponsor	Collaborator
Charite University, Berlin, Germany

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pelvic pain via pressure pain threshold	pressure pain threshold	4 weeks